Onesource Specialty Pharma Limited — Board Meeting, 13-05-2026: Outcome of Board Meeting
13-05-2026 · 12:59 pm
OneSource Pharma's board has approved the financial results for the quarter and year ended March 31, 2026. Additionally, B S R & Co LLP will take over as statutory auditors for five years, replacing Deloitte Haskins & Sells, pending shareholder nod.
No comments yet. Be the first to comment!
